A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 458 participants.
Also called NCT05427786
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 458 participants
- Sponsor
- Registry
-
NCT05427786
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT05427786. Randomized; no masking; primary purpose prevention. Start 2022-12-14 (actual); primary completion 2027-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
- Condition
- No-Reflow Phenomenon
- Condition
- Coronary Artery Disease
- Condition
- Percutaneous Coronary Intervention
- Intervention (Drug)
- Nicorandil
- Lead sponsor
- Korea University Anam Hospital
- Collaborator
- Hanyang University Seoul Hospital
- Collaborator
- InjeUniversityIlsanPaikHospital
- Collaborator
- Ajou University School of Medicine
Record details
- Record id
cardio:ct-nct05427786- Content hash
bcc1a46d5eaaf43f3463f5ba7622b0ef2e9f91198460604b62375c8c02c14bc7